National Cancer Institute (NCI)s

National Cancer Institute (NCI)

412 Protocols (223 Active Accrual of new subjects, 189 Follow-up of previously enrolled subjects)

 05-C-0152:

Variation in Gene Expression in Neurofibromatosis Type 1

 04-C-0275:

Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity

 04-C-0238:

A Phase 2 Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors

 04-C-0232:

A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse

 02-C-0268:

Prospective Study of Prophylactic Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer

 02-C-0212:

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

 02-C-0210:

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

 02-C-0178:

Multidisciplinary Etiologic Study of Familial Testicular Cancer

 01-C-0030:

Short-Course EPOCH - Rituximab in Untreated CD-20+ HIV-Associated Lymphomas

 01-C-0009:

Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study

 99-C-0099:

Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

 78-C-0039:

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

Previous 100 Protocols